The CD8⁺ T Cell Noncytotoxic Antiviral Responses.

Area of Science:

• Immunology
• Virology
• Infectious Diseases

Background:

• CD8+ T cell noncytotoxic antiviral response (CNAR) identified in asymptomatic HIV subjects.
• CNAR suppresses HIV replication without target cell killing, unlike cytotoxic lymphocyte (CTL) activity.
• CNAR exhibits innate immunity characteristics, acting on retroviruses without epitope specificity or HLA restriction.

Purpose of the Study:

• To describe assays for measuring CNAR/CAF.
• To review the effects of CNAR/CAF on retrovirus infections.
• To discuss the potential of CNAR/CAF for HIV/AIDS therapeutic and preventive strategies.

Main Methods:

• Description of various assays to measure CNAR/CAF activity.
• Review of studies on CNAR/CAF effects on different retroviruses.
• Discussion of challenges in characterizing the CAF protein structure.

Main Results:

• CNAR suppresses HIV replication via CD8+ T cell antiviral factor (CAF) blocking transcription.
• CNAR is specific to retroviruses and does not affect other virus families.
• CD8+ T cell noncytotoxic antiviral responses observed in other virus families involve different cytokines.

Conclusions:

• CNAR/CAF represents a natural, non-killing antiviral activity against HIV.
• Characterizing the low-abundance CAF protein remains a challenge, potentially aided by next-generation sequencing.
• CNAR/CAF offers promising avenues for HIV/AIDS therapy, cure, and prevention.